Data / Form D filings / M Pharmaceutical Inc.
M Pharmaceutical Inc.: Form D filing
M Pharmaceutical Inc., a pharmaceuticals company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2016. The latest, on October 25, 2016, reports $25,832 sold of a $25,832 offering to 5 investors.
Find out what M Pharmaceutical Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 734-1055 DUNSMUIR STREET, Vancouver, British Columbia, Canada, V7X 1
- Phone
- (604) 428-0511
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Alberta, Canada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1687423
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 25, 2016 | New notice | $25,832 | $25,832 | $0 | 5 | Sep 7, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tatiana D. Kovalena | Executive Officer | |
| Christopher Andrews | Director | |
| George Tsfalas | Director | |
| Gary D. Thompson | Executive Officer | |
| Brian D. Keane | Executive Officer | |
| Rick Skeith | Director |
Every Form D from the week of Oct 24, 2016 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what M Pharmaceutical Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.